Special items: Ovarian Cancer and Us blog best viewed in Firefox

Friday, January 21, 2011

Cantech Letter interviews Brad Thompson President and CEO of Oncolytics Biotech (Reolysin, GOG, clinical trials)


No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.